Canada Anti Aging Therapeutics Market Report 2022 to 2030

Canada Anti Aging Therapeutics Market Analysis

$ 3999

Canada's anti-ageing therapeutics market is likely to grow at a CAGR of 16.53% from a market size of $54 Mn in 2022 to $164 Mn in 2030. The major growth drivers driving the market are the growing ageing population and the trend of the shift toward preventive healthcare. This report is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Some key players in this market include Pfizer, Bristol-Myers Squibb Company, Merck, Calico, and others.

ID: IN10CAPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Dhruv Joshi

Buy Now

Canada Anti-Aging Therapeutics Market Executive Summary

Canada's anti-ageing therapeutics market is likely to grow at a CAGR of 16.53% from a market size of $54 Mn in 2022 to $164 Mn in 2030. One of the largest nations in the globe and the largest in the western hemisphere is Canada. With firms ranging from little owner-managed businesses to multinational corporations, it boasts a thriving free-market economy. In the past, the export of agricultural staples, primarily grain, as well as the production and sale of natural resource exports, such as minerals, oil and gas, and forest products, were the foundations of Canada's economy.

The public sector finances healthcare services and the private sector provides these services, in Canada's hybrid public-private healthcare system. There is currently no national procurement model that is uniform. Each province like British Columbia, Ontario, Quebec, Saskatchewan, and others has its own set of regulations, which can vary significantly between regions or service providers. Provincial governments are implementing or looking at healthcare procurement reforms, including centralized approaches. The Canadian pharmaceutical market was valued at USD 29,305.1 million in 2021. It is expected to reach USD 39,427.4 million by 2027, registering a CAGR of 5.26% during 2022-2027. A variety of treatments, drugs, and lifestyle changes that slow down or stop the biological aging process are referred to as anti-aging therapy. Anti-aging therapies aim to increase a person's healthy lifespan and lower the prevalence of age-related illnesses such as dementia, cardiovascular disease, cancer, and diabetes.

canada anti aging therapeutics market

Market Dynamics

Market Growth Drivers

The aging population in Canada is one of the main factors driving the anti-aging business there. The number of Canadians 65 and older is anticipated to rise dramatically in the upcoming years, according to Statistics Canada. With the purpose of preserving a young appearance and fending off the consequences of aging, this group is more inclined to look into anti-aging treatments and therapies. The rising disposable income of Canadians is another element boosting the anti-aging business in that country. More people are able to pay the price of anti-aging treatments and therapies, such as cosmetic surgeries, skincare products, and supplements, as disposable incomes rise.

Canadians are becoming more and more aware of the advantages of anti-aging goods and services. This is partly because there is more information available on social media, internet forums, and other platforms. Customers are willing to try new goods and therapies in order to appear and feel younger and are getting more knowledgeable about the most recent anti-aging treatments. The rising demand for minimally invasive procedures like Botox injections, dermal fillers, and laser treatments is another factor driving the anti-aging market in Canada. These methods can produce good results with less recovery time since they are less intrusive than conventional surgical procedures.

Market Restraints

Some Canadians may find the cost of anti-aging therapy and procedures to be unaffordable. Patients must pay for many procedures out of pocket because public health insurance does not always cover them. Some people who are interested in anti-aging treatments but cannot afford the expense may find this to be a substantial barrier. Natural remedies, exercise, and a nutritious diet are just a few examples of non-pharmaceutical alternatives to anti-aging treatments and therapies. Some Canadians may find these alternatives to be more affordable and available, which could reduce the demand for anti-aging goods and services.

Competitive Landscape

Key Players

Pfizer
Bristol-Myers Squibb Company
Merck
Calico
Life Biosciences

Healthcare Policies and Regulatory Landscape

Strict guidelines for the security, effectiveness, and caliber of anti-aging goods and treatments are set by Health Canada, the federal regulatory body in charge of authorizing medications and medical equipment. Anti-aging products and therapies must go through extensive research and clinical trials to show their safety and efficacy before they can be used in Canada. Following an evaluation of the findings from these studies, Health Canada decides whether to approve the product for sale in Canada. Furthermore, Health Canada mandates that the production and distribution of anti-aging products and therapies must adhere to high-quality requirements.

Good Manufacturing Practices (GMP) regulations must be followed by manufacturers to guarantee that products are manufactured in a secure environment under strict control and that they fulfill high-quality requirements. After anti-aging products and therapies hit the market, Health Canada keeps an eye on their efficacy and safety. The agency has the power to fine manufacturers that do not follow regulations or to recall products that are discovered to be harmful.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.